KLHL14: A Novel Prognostic Biomarker and Therapeutic Target for Ovarian Cancer

Figure 4

(a) Lollipop charts of the mutated KLHL14 gene, the somatic mutation rate and the name of somatic mutation. (b–c) Oncoplot shows the somatic landscape of the OV cohort ((b) low expression group, (c) high expression group). Genes and samples were ordered based on their mutation frequencies and disease histology, respectively, as shown by the annotation bar.

(a)

(b)

(c)